What amount sold does 4C Medical Technologies, Inc. report in Form D filings?

The latest linked filings report $145.5M sold across 7 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was 4C Medical Technologies, Inc.'s most recent SEC filing?

4C Medical Technologies, Inc.'s most recent Form D filing was on 2026-03-31.

How many investors does 4C Medical Technologies, Inc. have?

The most recent Form D filing lists 80 investor(s).

What type of securities does 4C Medical Technologies, Inc. offer?

4C Medical Technologies, Inc.'s SEC Form D filings indicate equity offerings.

4C Medical Technologies, Inc.

CIK: 0001692028·Other Technology·Maple Grove, MN·Corporation

Reported Sold

$145,528,177

Total Filings

Identified Offerings

Last Filed

Mar 31, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Other Technology industry

SEC EDGAR

Offering filing timeline

Mar 31, 2026Form D/A — Amendment

Reported sold: $71,608,160 · Target: $166,095,595

Rule 506(b)·80 investors

Mar 19, 2025Form D — New notice

Reported sold: $71,608,160 · Target: $166,095,595

Rule 506(b)·80 investors

Nov 16, 2021Form D — New notice

Reported sold: $35,250,865 · Target: $60,611,200

Rule 506(b)·53 investors

Jun 30, 2021Form D/A — Amendment

Reported sold: $10,000,000 · Target: $10,000,000

Rule 506(b)·39 investors

Changed: Reported amount sold, Reported investors

Jun 2, 2020Form D — New notice

Reported sold: $100,000 · Target: $10,000,000

Rule 506(b)·1 investor

Oct 2, 2019Form D — New notice

Reported sold: $8,188,818 · Target: $20,000,000

Rule 506(b)·45 investors

Sep 19, 2018Form D — New notice

Reported sold: $17,347,720 · Target: $25,000,000

Rule 506(b)·23 investors

May 17, 2018Form D — New notice

Reported sold: $3,072,614 · Target: $15,000,000

Rule 506(b)·29 investors

Dec 14, 2016Form D — New notice

Reported sold: $60,000 · Target: $2,000,000

Rule 506(b)·1 investor

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

$9,295,063

Amendment Rate

22%

Latest reported sold across 7 identified offerings

$145,528,177

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Jonathan Chen

Related Person

Appears on 6 filings

Katherine Kumar

Related Person

Appears on 6 filings

Saravana Kumar

Related Person

Appears on 6 filings

Buzz Benson

Related Person

Appears on 6 filings

Jeffrey W. Chambers

Related Person

Appears on 4 filings

Rhonda Robb

Related Person

Appears on 3 filings

Jeffrey W. Chambers

Related Person

Appears on 3 filings

Jeffrey Chambers

Related Person

Appears on 2 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Mar 31, 2026	Amendment	$166,095,595	$71,608,160	80
Mar 19, 2025	New	$166,095,595	$71,608,160	80
Nov 16, 2021	New	$60,611,200	$35,250,865	53
Jun 30, 2021	Amendment	$10,000,000	$10,000,000	39
Jun 2, 2020	New	$10,000,000	$100,000	1
Oct 2, 2019	New	$20,000,000	$8,188,818	45
Sep 19, 2018	New	$25,000,000	$17,347,720	23
May 17, 2018	New	$15,000,000	$3,072,614	29
Dec 14, 2016	New	$2,000,000	$60,000	1

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

BIOMETRICA HEALTH, INC.

Other Technology

Offering target: $2,000,000

Filed Oct 28, 2026